EP1244673A2 - Nouveaux imidazo 1,3,5]triazinones et leur utilisation - Google Patents

Nouveaux imidazo 1,3,5]triazinones et leur utilisation

Info

Publication number
EP1244673A2
EP1244673A2 EP00993611A EP00993611A EP1244673A2 EP 1244673 A2 EP1244673 A2 EP 1244673A2 EP 00993611 A EP00993611 A EP 00993611A EP 00993611 A EP00993611 A EP 00993611A EP 1244673 A2 EP1244673 A2 EP 1244673A2
Authority
EP
European Patent Office
Prior art keywords
hydrogen
different
alkyl
diseases
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00993611A
Other languages
German (de)
English (en)
Inventor
Ulrich Niewöhner
Helmut Haning
Thomas Lampe
Mazen Es-Sayed
Gunter Schmidt
Erwin Bischoff
Klaus Dembowsky
Elisabeth Perzborn
Karl-Heinz Schlemmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999162928 external-priority patent/DE19962928A1/de
Priority claimed from DE10003323A external-priority patent/DE10003323A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of EP1244673A2 publication Critical patent/EP1244673A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne des nouveaux imidazo[1,3,5]triazinones de la formule générale (I), leur procédé de production et leur utilisation comme médicaments, en particulier en tant qu'inhibiteurs des phosphodiestérases métabolisant le GMP cyclique.
EP00993611A 1999-12-24 2000-12-12 Nouveaux imidazo 1,3,5]triazinones et leur utilisation Withdrawn EP1244673A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19962928 1999-12-24
DE1999162928 DE19962928A1 (de) 1999-12-24 1999-12-24 Neue Imidazo[1,3,5]triazinone und ihre Verwendung
DE10003323A DE10003323A1 (de) 2000-01-27 2000-01-27 Neue Imidazo[1,3,5[triazinone und ihre Verwendung
DE10003323 2000-01-27
PCT/EP2000/012597 WO2001047928A2 (fr) 1999-12-24 2000-12-12 Nouveaux imidazo[1,3,5]triazinones et leur utilisation

Publications (1)

Publication Number Publication Date
EP1244673A2 true EP1244673A2 (fr) 2002-10-02

Family

ID=26004043

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00993611A Withdrawn EP1244673A2 (fr) 1999-12-24 2000-12-12 Nouveaux imidazo 1,3,5]triazinones et leur utilisation

Country Status (13)

Country Link
US (2) US6803365B2 (fr)
EP (1) EP1244673A2 (fr)
JP (1) JP2003519150A (fr)
KR (1) KR20020062770A (fr)
CN (1) CN1434825A (fr)
AU (1) AU781028B2 (fr)
BR (1) BR0017043A (fr)
CA (1) CA2395548A1 (fr)
IL (1) IL150022A0 (fr)
MX (1) MXPA02006240A (fr)
PL (1) PL356848A1 (fr)
TR (1) TR200201638T2 (fr)
WO (1) WO2001047928A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230154B1 (hu) * 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
CA2395548A1 (fr) * 1999-12-24 2001-07-05 Bayer Aktiengesellschaft Nouveaux imidazo[1,3,5]triazinones et leur utilisation
CA2417631A1 (fr) * 2000-08-01 2003-01-29 Bayer Aktiengesellschaft Inhibiteurs selectifs de pde 2 comme medicaments ameliorant la perception
BR0209541A (pt) * 2001-05-09 2004-04-20 Bayer Healthcare Ag Uso das imidazotriazinonas 2-fenil-substituìdas
GB0126417D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Crystal structure
PL205936B1 (pl) 2002-02-22 2010-06-30 Schering Corp Farmaceutyczny preparat zawierający termozolomid oraz sposób jego wytwarzania
DE10224462A1 (de) * 2002-06-03 2003-12-11 Bayer Ag Verwendung von cGMP stimulierenden Verbindungen
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
UY28213A1 (es) * 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
CN1548438A (zh) * 2003-05-16 2004-11-24 烟台开发区北方药物研究所 2-取代苯基-6,8-二烃基-3H-咪唑[1,5α][1,3,5]三嗪-4-酮衍生物,其制备方法及其药物用途
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体
JP2007512242A (ja) * 2003-10-29 2007-05-17 イーラン ファーマスーティカルズ、インコーポレイテッド Ｎ−置換ベンゼンスルホンアミド
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
DE102004038328A1 (de) * 2004-08-06 2006-03-16 Bayer Healthcare Ag Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
EA018668B1 (ru) * 2005-02-18 2013-09-30 Сурфейс Логикс Инк. Фармакокинетически улучшенные соединения
JP2008530246A (ja) * 2005-02-18 2008-08-07 サーフェイス ロジックス，インコーポレイティド 機能性残基又は官能基を含む薬物動態学的に改善された化合物、及び上述の化合物を含む医薬組成物の製造方法
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
BRPI0616633A2 (pt) * 2005-09-29 2011-06-28 Bayer Healthcare Ag inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos
EP1984321A1 (fr) * 2006-02-17 2008-10-29 Wyeth Méthodes de synthèse d'alcools substitués par sulfonamide et intermédiaires correspondants
KR20080094685A (ko) * 2006-02-17 2008-10-23 와이어쓰 2-아미노 플루오로- 및 트리플루오로알킬 치환된 알코올의 선택적 ｎ-술폰화
JP5539717B2 (ja) * 2006-07-14 2014-07-02 塩野義製薬株式会社 オキシム化合物およびその使用
EP2061322B1 (fr) 2006-08-24 2015-07-01 Surface Logix, Inc. Composés de pharmacocinétique améliorée
BRPI0823416A2 (pt) * 2007-05-08 2015-06-16 Schering Corp Métodos de tratamento usando formulações intravenosas compreendendo temozolomida.
JP2010532319A (ja) * 2007-06-13 2010-10-07 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 聴覚障害の処置用のｐｄｅ阻害剤
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
CN113461694A (zh) * 2021-08-05 2021-10-01 广东西捷药业有限公司 一种伐地那非类似物及其合成方法和应用
CN113583003A (zh) * 2021-08-05 2021-11-02 广东西捷药业有限公司 一种伐地那非类似物及其合成方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9218322D0 (en) 1992-08-28 1992-10-14 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
ZA969888B (en) 1995-11-28 1997-05-26 Schering Corp 2'-[[4'-halo-[1,1-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7'(8'H)-[3H]imidazo[2,1-b]purin]-4'(5'H)-ones
EA004315B1 (ru) 1997-04-25 2004-02-26 Пфайзер Инк. Новые сульфонилбензойные кислоты и способ получения 4-бензамидопиразоло-5-карбоксамидов с их использованием
HU230154B1 (hu) 1997-11-12 2015-09-28 Bayer Intellectual Property Gmbh Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
CA2395548A1 (fr) * 1999-12-24 2001-07-05 Bayer Aktiengesellschaft Nouveaux imidazo[1,3,5]triazinones et leur utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0147928A2 *

Also Published As

Publication number Publication date
US20050043303A1 (en) 2005-02-24
US6803365B2 (en) 2004-10-12
TR200201638T2 (tr) 2002-11-21
CN1434825A (zh) 2003-08-06
AU781028B2 (en) 2005-04-28
CA2395548A1 (fr) 2001-07-05
KR20020062770A (ko) 2002-07-29
BR0017043A (pt) 2003-01-07
WO2001047928A3 (fr) 2002-05-16
JP2003519150A (ja) 2003-06-17
MXPA02006240A (es) 2003-01-28
AU2842001A (en) 2001-07-09
US7091203B2 (en) 2006-08-15
WO2001047928A2 (fr) 2001-07-05
PL356848A1 (en) 2004-07-12
US20030195210A1 (en) 2003-10-16
IL150022A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
EP1244673A2 (fr) Nouveaux imidazo 1,3,5]triazinones et leur utilisation
EP1049695B1 (fr) Imidazotriazinones a substitution 2-phenyle utilisees comme inhibiteurs des phosphodiesterases
EP1107968B1 (fr) Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidine-7-one
EP1534713B1 (fr) Pyrazolopyrimidines substituees par alkyle
EP1280805B1 (fr) Nouvelles imidazotriazinones et leur utilisation
EP1090003A1 (fr) Imidazotriazinones a substitution 7-alkyle et cycloalkyle
EP1534711A1 (fr) Pyrazolopyrimidines substituees par phenyle
EP1261609B1 (fr) Triazolotriazinones et leur utilisation
WO2002064593A1 (fr) Imidazotriazinones 2-alcoxyphenyl-substituees
WO2000011002A1 (fr) Derives du type 9-dialkylaminopurinone
DE19702785A1 (de) Neue cyclische Harnstoffderivate
DE19962928A1 (de) Neue Imidazo[1,3,5]triazinone und ihre Verwendung
DE19812462A1 (de) 2-[2-Ethoxy-5(4-ethyl-piperazin-1-sulfonyl) -phenyl]-5-methyl-7-prophyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on Dihydrochlorid
EP1252165A1 (fr) Isoxazolopyrimidinones et leur utilisation
DE10003323A1 (de) Neue Imidazo[1,3,5[triazinone und ihre Verwendung
DE19962927A1 (de) Neue Triazolotriazinone und ihre Verwendung
DE10003296A1 (de) Neue Triazolotriazinone und ihre Verwendung
DE19750085A1 (de) 2-Phenyl-substituierte Imidazotriazinone
DE10003287A1 (de) Neue Isoxazolopyrimidinone und ihre Verwendung
DE19962925A1 (de) Neue Isoxazolopyrimidinone und ihre Verwendung
DE19840289A1 (de) 2-Phenyl-substituierte Imidazotriazinone

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20021118

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER HEALTHCARE AG

RTI1 Title (correction)

Free format text: NOVEL IMIDAZO 1,3,5 TRIAZINONES AND THE USE THEREOF

17Q First examination report despatched

Effective date: 20080402

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080813